Evidence-based practices

Newsweek in Partnership with The Leapfrog Group Awards Magnolia Medical's Steripath Platform as Category-Exclusive Best Infection Prevention Product of 2021

Retrieved on: 
Tuesday, July 27, 2021
Health, Health care quality, Evidence-based practices, Medical terminology, Infectious diseases, Patient safety, Medical guideline, Magnolia, Infection prevention and control

SEATTLE, July 27, 2021 /PRNewswire/ --Magnolia Medical announced today that Newsweek, in partnership with The Leapfrog Group, an independent, nonprofit healthcare industry watchdog organization that evaluates healthcare quality, designated the Steripath Initial Specimen Diversion Device as a Best Infection Prevention Product of 2021 .

Key Points: 
  • SEATTLE, July 27, 2021 /PRNewswire/ --Magnolia Medical announced today that Newsweek, in partnership with The Leapfrog Group, an independent, nonprofit healthcare industry watchdog organization that evaluates healthcare quality, designated the Steripath Initial Specimen Diversion Device as a Best Infection Prevention Product of 2021 .
  • This is the second year in a row Steripath has been the only blood culture collection and contamination reduction system named to the distinguished list.
  • This recognition, along with major formal policy and guideline changes, affirm the criticality of our Steripath technology platform to help solve this longstanding patient safety and healthcare quality issue."
  • Magnolia Medical invented and patented the Initial Specimen Diversion Technique (ISDT) and Device (ISDD) for blood culture collection and contamination prevention.

ObservSMART Delivers Patient Safety Technology to Behavioral Health Units

Retrieved on: 
Wednesday, July 14, 2021
Health care quality, Evidence-based practices, Patient safety

HOUSTON, July 14, 2021 /PRNewswire/ -- ObservSMART , a patient safety compliance tool, continues to rollout the company's technology to health care institutions to help ensure safety with consistent monitoring and observation of patients in behavioral health units.

Key Points: 
  • HOUSTON, July 14, 2021 /PRNewswire/ -- ObservSMART , a patient safety compliance tool, continues to rollout the company's technology to health care institutions to help ensure safety with consistent monitoring and observation of patients in behavioral health units.
  • ObservSMART is part of InvisAlert Solutions, which develops products designed to improve patient safety and quality of care for high-risk patient populations, including those with depression, anxiety, and suicidal tendencies.
  • Designed by and specifically for behavioral health and addiction treatment professionals, ObservSMART is a proximity-based patient check system that syncs a patented tamper-resistant wristband and tablet.
  • ObservSMART is InvisAlert Solutions' patient safety compliance tool that ensures patient safety by validating and documenting patient safety checks.

BioSyent Signs Exclusive Technology Agreement

Retrieved on: 
Tuesday, July 13, 2021
Health care quality, Evidence-based practices

MISSISSAUGA, Ontario, July 13, 2021 (GLOBE NEWSWIRE) -- BioSyent Inc. (BioSyent, TSX Venture: RX) is pleased to announce that its subsidiary, BioSyent Pharma Inc., has signed an agreement to license a unique technology application to support better treatment outcomes for patients with iron deficiencies in Canada and BioSyents international markets.

Key Points: 
  • MISSISSAUGA, Ontario, July 13, 2021 (GLOBE NEWSWIRE) -- BioSyent Inc. (BioSyent, TSX Venture: RX) is pleased to announce that its subsidiary, BioSyent Pharma Inc., has signed an agreement to license a unique technology application to support better treatment outcomes for patients with iron deficiencies in Canada and BioSyents international markets.
  • BioSyent is a leader and innovator in this therapeutic area and this initiative is another step towards better overall iron health for patients.
  • We look forward to making this convenient technology available to Canadians and their healthcare providers in the 2nd half of 2021.
  • BioSyent supports the healthcare professionals that treat these patients by marketing its products through its community, specialty, and international business units.

VoiceFriend Adds New Discharged Patient Module to its Popular Integrated Messaging and Engagement Solution

Retrieved on: 
Thursday, June 10, 2021
Health, Health care quality, Electronic health records, Health informatics, Patient, Evidence-based practices

BOSTON , June 10, 2021 /PRNewswire-PRWeb/ -- VoiceFriend, LLC significantly enhances its premier Integrated Messaging and Engagement solution with the release of its new Discharged Patient module.

Key Points: 
  • BOSTON , June 10, 2021 /PRNewswire-PRWeb/ -- VoiceFriend, LLC significantly enhances its premier Integrated Messaging and Engagement solution with the release of its new Discharged Patient module.
  • This first-of-its-kind module was specifically designed to help post-acute care providers optimize discharged patient engagement, better ensuring patient well-being and satisfaction, and meet hospital network requirements all while boosting census and increasing referrals.
  • To help them achieve these goals, we worked closely with care providers to develop our new Discharged Patient module.
  • VoiceFriend's Discharged Patient module is included as part of its robust, proven Integrated Messaging and Engagement solution designed to boost the engagement, wellness/safety, and satisfaction of patients, seniors and families while increasing staff productivity.

Pennsylvania's Acting Physician General, Dr. Denise A. Johnson Named Chair of Patient Safety Authority Board

Retrieved on: 
Friday, June 4, 2021
Evidence-based practices, Patient safety, Health, Health care quality, Patient, Patient safety organization

HARRISBURG, Pa., June 4, 2021 /PRNewswire/ -- Governor Tom Wolf has appointed Acting Physician General of Pennsylvania, Dr. Denise A. Johnson, as chair of the Patient Safety Authority (PSA) board of directors.

Key Points: 
  • HARRISBURG, Pa., June 4, 2021 /PRNewswire/ -- Governor Tom Wolf has appointed Acting Physician General of Pennsylvania, Dr. Denise A. Johnson, as chair of the Patient Safety Authority (PSA) board of directors.
  • Dr. Johnson received her medical degree from Georgetown University School of Medicine and is a Fellow of the American College of Healthcare Executives.
  • "The Patient Safety Authority plays a vital role by identifying systemic problems, helping individual healthcare facilities and educating both practitioners and the public about health issues," said Dr. Johnson.
  • The PSA is an independent state agency that collects and analyzes patient safety data to improve safety outcomes and help prevent patient harm.

Five-year patient-level meta-analysis of ILLUMENATE EU RCT and Pivotal study results confirms safety profile of Philips Stellarex .035” low-dose Drug-Coated Balloon

Retrieved on: 
Tuesday, April 20, 2021
Evidence-based practices, Carbonyl compounds, Oxygen compounds, Clinical research, Systematic review, Evidence, Meta-analysis, Hierarchy of evidence, Paclitaxel

The findings, which represent the highest level of the evidence pyramid [1], confirm the long-term safety of the Philips Stellarex Drug-Coated Balloon (DCB).

Key Points: 
  • The findings, which represent the highest level of the evidence pyramid [1], confirm the long-term safety of the Philips Stellarex Drug-Coated Balloon (DCB).
  • The meta-analysis was presented at the 2021 Charing Cross International Symposium .\nThe ILLUMENATE EU RCT and ILLUMENATE Pivotal RCT meta-analysis comprises approximately 600 patients in Europe and the U.S., and is the largest homogenous patient data set of paclitaxel DCB RCTs with five-year follow-up [2,3].
  • The analysis also demonstrates that the use of one or multiple Stellarex DCBs in a patient is not a predictor of mortality.
  • Paclitaxel exposure: Long-term safety and effectiveness of a drug-coated balloon for claudication in pooled randomized trials.

CareView Communications Announces Sales For Q4 2020

Retrieved on: 
Tuesday, April 13, 2021
Software, Audio, Video, Hardware, General Health, Health, Data management, Hospitals, Technology, Evidence-based practices, Health care quality, Patient safety

b'CareView Communications, Inc. ("CareView" or the "Company") (OTCQB: CRVW), an information technology provider to the healthcare industry, today announced that new sales-based contracts were executed in the fourth quarter of 2020 with an aggregated contract sales price of $1,800,000.

Key Points: 
  • b'CareView Communications, Inc. ("CareView" or the "Company") (OTCQB: CRVW), an information technology provider to the healthcare industry, today announced that new sales-based contracts were executed in the fourth quarter of 2020 with an aggregated contract sales price of $1,800,000.
  • CareView expects that the bulk of new contracts to be executed in fiscal year 2021 will be sales-based.
  • CareView continues to bill the facility an annual software license fee until end of the contract.
  • Anchored by the CareView Patient Safety System, this modular, scalable solution delivers flexible configurations to fit any facility while significantly increasing patient safety and operational savings.

Pear Therapeutics and Prescryptive Health Announce Formulary Coverage for Prescription Digital Therapeutics reSET® & reSET-O® for the Treatment of Substance and Opioid Use Disorders

Retrieved on: 
Thursday, April 1, 2021
Software, Biotechnology, Pharmaceutical, General Health, Health, FDA, Technology, Clinical trials, Clinical research, Health sciences, Design of experiments, Health, Medical research, Evidence-based practices, Pharmaceutical industry, Causal inference, Randomized controlled trial, Reset, Trials, Clinical trial

With this coverage decision, Pear continues to expand access to PDTs by adding reSET and reSET-O to a standard formulary.

Key Points: 
  • With this coverage decision, Pear continues to expand access to PDTs by adding reSET and reSET-O to a standard formulary.
  • Prescryptive will include reSET and reSET-O on its platform, making a seamless experience for members who will benefit from PDTs.
  • Both reSET and reSET-O have been tested in real-world use and randomized controlled trials, with results published in peer-reviewed medical journals.
  • Pear recently released publications showing the potential for improved health outcomes and decreased treatment costs for patients using reSET-O3-7.

Dr. Rebekah Gee Joins the TPN.health Team as a Senior Advisor to Provide Critical Behavioral Health Resources to Licensed Clinicians

Retrieved on: 
Wednesday, March 31, 2021
Evidence-based practices, Health care quality, Patient safety, Gee, Health, Rebekah Gee

Dr. Gee is the former Secretary of the Louisiana Department of Health and a practicing Obstetrician Gynecologist.

Key Points: 
  • Dr. Gee is the former Secretary of the Louisiana Department of Health and a practicing Obstetrician Gynecologist.
  • During her career in public office, Dr. Gee has been a consistent voice for healthcare quality and patient safety.
  • According to Dr. Gee, "Awareness of the critical need to expand and improve behavioral health services has grown exponentially during COVID 19.
  • As a senior advisor, Dr. Gee will help TPN expand its presence through her role in addressing national issues concerning behavioral health.

Hiring for the Future: Cross Country Healthcare Announces Innovative Virtual Patient Observation Partnership

Retrieved on: 
Thursday, March 25, 2021
Technology, Nursing, Human resources, Hospitals, Professional services, Audio, Video, Software, Health, General Health, Health care quality, Evidence-based practices, Nursing, Patient safety, Articles, Cross Country Healthcare, Wachter Healthcare Solutions

Cross Country Healthcare, Inc., (NASDAQ: CCRN), a leading provider of advisory and workforce solutions including contingent staffing, permanent placement and other consultative services for healthcare clients, is partnering with Wachter Healthcare Solutions to hire patient observation teams and implement innovative virtual patient observation (VPO) technology.

Key Points: 
  • Cross Country Healthcare, Inc., (NASDAQ: CCRN), a leading provider of advisory and workforce solutions including contingent staffing, permanent placement and other consultative services for healthcare clients, is partnering with Wachter Healthcare Solutions to hire patient observation teams and implement innovative virtual patient observation (VPO) technology.
  • Wachter Healthcare Solutions designs and installs a powerful remote patient observation and patient safety solution known as NOVA (Nursing Observation and Virtual Assistant).
  • Part of Cross Country Healthcares core mission is to seek out and implement technology that helps our clients improve both patient outcomes and cost efficiency, says Kevin C. Clark, co-founder and CEO of Cross Country Healthcare.
  • This innovative partnership combines with Cross Country Healthcare to supply and place observation technician candidates in healthcare facilities.